Advertisement

Topics

Batu Biologics Publishes Mechanistic Preclinical Data for ValloVax

09:30 EST 3 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company authors peer reviewed publication describing the mechanism of action of the ValloVax™ mediated immune response Batu Biologics, a biopharmaceutical company developing next generation immuno-oncology therapeutics, an...

Other Sources for this Article

Batu Biologics Inc.
Dimitri Theofilopoulos, J.D.
Chief Operations Officer
Phone 213-359-3179
Fax 858-597-7090
dimitri.theo@batubiologics.com
www.batubiologics.com
(No Solicitations)

NEXT ARTICLE

More From BioPortfolio on "Batu Biologics Publishes Mechanistic Preclinical Data for ValloVax"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...